EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

CHEK2 germline gene variant in a patient with a somatotrophinoma and primary hyperparathyroidism: a novel MEN1-like syndrome?

Durairaj Arjunan iD, Mohammad Hayat Bhat iD, Ashutosh Rai iD, Vaishali Kaur iD, Sayka Barry iD, Md Ejaz Alam iD, Mohammad Salem Baba iD, Ajay Gulati iD, Debajyoti Chatterjee iD, Manzoor Ahmad Latoo iD, Márta Korbonits iD, Ashley B Grossman iD und 1 weitere

Endocrine Oncology · 01.01.2026 · 6 (1)

DOI: 10.1530/eo-25-0100 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrine Oncology, online erschienen am 29.07.2026. Verfasst von Durairaj Arjunan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, PGIMER, Chandigarh, India. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Somatotrophinomas can occasionally occur in familial settings and may be associated with known germline mutations, such as MEN1, AIP, CDKN1B, PRKAR1A, SDHx, and MAX. Recently, the CHEK2 gene has emerged as a potential pituitary tumour predisposition gene.

Objective

To present a rare case of a patient with a pituitary somatotrophinoma and primary hyperparathyroidism (PHPT) associated with a likely pathogenic CHEK2 germline mutation, suggesting a novel MEN1-like phenotype.

Methods

We conducted a detailed clinical, biochemical, radiological, and genetic evaluation of a 38-year-old woman presenting with features of acromegaly and PHPT. Genetic testing for known MEN1 syndrome-associated genes and broader pituitary tumour predisposition genes was performed.

Results

The patient presented with features of acromegaly of 3 years duration and a collagenoma. Laboratory evaluation revealed an elevated IGF-1. Biochemical and imaging studies also revealed PTH-dependent hypercalcaemia and bilateral inferior parathyroid adenomas. Genetic testing for a panel of genes causing hypercalcaemia – including MEN1 and CDKN1B – was negative; however, a pathogenic nonsense variant in CHEK2 (c.232C>T; p.(Gln78Ter); gnomAD frequency: 0.0006%) was detected with exome sequencing. The patient underwent transsphenoidal resection of the pituitary tumour followed by gamma-knife radiosurgery and received long-acting octreotide every four weeks. Parathyroidectomy was performed 1.5 years later.

Conclusion

This is the first reported case of a CHEK2 germline mutation associated with somatotrophinoma, PHPT, and collagenoma, mimicking the clinical MEN1 syndrome. These findings expand the spectrum of possible CHEK2-associated neoplasia and highlight the need to consider CHEK2 as a possible candidate gene in patients with MEN1-like syndromes when common mutations have been excluded.

Schlagwörter

Stichwörter der Autor:innen

CHEK2MEN 1 phenocopyacromegalygenehyperparathyroidism

Autor:innen und Institutionen

  • Department of Endocrinology, PGIMER, Chandigarh, India.
  • Department of Endocrinology, Government Medical College Super Speciality Hospital Srinagar, Srinagar, India.
  • Department of Biochemistry, Panjab University, Chandigarh, India.
  • Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Department of Radio-Diagnosis, PGIMER, Chandigarh, India.
  • Department of Histopathology, PGIMER, Chandigarh, India.

ORCID-Profile: Durairaj Arjunan, Mohammad Hayat Bhat, Ashutosh Rai, Vaishali Kaur, Sayka Barry, Md Ejaz Alam, Mohammad Salem Baba, Ajay Gulati, Debajyoti Chatterjee, Manzoor Ahmad Latoo, Márta Korbonits, Ashley B Grossman, Pinaki Dutta

Zitieren

APA

Arjunan, D., Bhat, M. H., Rai, A., Kaur, V., Barry, S., Alam, M. E., Baba, M. S., Gulati, A., Chatterjee, D., Latoo, M. A., Korbonits, M., Grossman, A. B., & Dutta, P. (2026). CHEK2 germline gene variant in a patient with a somatotrophinoma and primary hyperparathyroidism: a novel MEN1-like syndrome?. Endocrine Oncology, 6(1). https://doi.org/10.1530/eo-25-0100

Vancouver

Arjunan D, Bhat MH, Rai A, Kaur V, Barry S, Alam ME, et al. CHEK2 germline gene variant in a patient with a somatotrophinoma and primary hyperparathyroidism: a novel MEN1-like syndrome?. Endocrine Oncology. 2026;6(1). doi:10.1530/eo-25-0100

BibTeX
@article{Arjunan2026,
  author = {Arjunan, Durairaj and Bhat, Mohammad Hayat and Rai, Ashutosh and Kaur, Vaishali and Barry, Sayka and Alam, Md Ejaz and Baba, Mohammad Salem and Gulati, Ajay and Chatterjee, Debajyoti and Latoo, Manzoor Ahmad and Korbonits, Márta and Grossman, Ashley B and Dutta, Pinaki},
  title = {CHEK2 germline gene variant in a patient with a somatotrophinoma and primary hyperparathyroidism: a novel MEN1-like syndrome?},
  journal = {Endocrine Oncology},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1530/eo-25-0100}
}
Kostenlos starten →